Javascript must be enabled to continue!
Muscarinic receptor subtypes in neuronal and non‐neuronal cholinergic function
View through CrossRef
Summary1 Muscarinic M1–M5receptors mediate the metabotropic actions of acetylcholine in the nervous system. A growing body of data indicate they also mediate autocrine functions of the molecule. The availability of novel and selective muscarinic agonists and antagonists, as well asin vivogene disruption techniques, has clarified the roles of muscarinic receptors in mediating both functions of acetylcholine.2 Selective M1agonists or mixed M1agonists/M2antagonists may provide an approach to the treatment of cognitive disorders, while M3antagonism, or mixed M2/M3antagonists, are approved for the treatment of contractility disorders including overactive bladder and chronic obstructive pulmonary disease. Preclinical data suggest that selective agonism of the M4receptor will provide novel anti‐nociceptive agents, while therapeutics‐based upon agonism or antagonism of the muscarinic M5receptor have yet to be reported.3 The autocrine functions of muscarinic receptors broadly fall into two areas – control of cell growth or proliferation and mediation of the release of chemical mediators from epithelial cells, ultimately causing muscle relaxation. The former particularly are involved in embryological development, oncogenesis, keratinocyte function and immune responsiveness. The latter regulate contractility of smooth muscle in the vasculature, airways and urinary bladder.4 Most attention has focused on muscarinic M1or M3receptors which mediate lymphocyte immunoresponsiveness, cell migration and release of smooth muscle relaxant factors. Muscarinic M4receptors are implicated in the regulation of keratinocyte adhesion and M2receptors in stem cell proliferation and development. Little data are available concerning the M5receptor, partly due to the difficulties in defining the subtype pharmacologically.5 The autocrine functions of acetylcholine, like those in the nervous system, involve activation of several muscarinic receptor subtypes. Consequently, the role of these subtypes in autocrine, as well neuronal cholinergic systems, significantly expands their importance in physiology and pathophysiology.
Title: Muscarinic receptor subtypes in neuronal and non‐neuronal cholinergic function
Description:
Summary1 Muscarinic M1–M5receptors mediate the metabotropic actions of acetylcholine in the nervous system.
A growing body of data indicate they also mediate autocrine functions of the molecule.
The availability of novel and selective muscarinic agonists and antagonists, as well asin vivogene disruption techniques, has clarified the roles of muscarinic receptors in mediating both functions of acetylcholine.
2 Selective M1agonists or mixed M1agonists/M2antagonists may provide an approach to the treatment of cognitive disorders, while M3antagonism, or mixed M2/M3antagonists, are approved for the treatment of contractility disorders including overactive bladder and chronic obstructive pulmonary disease.
Preclinical data suggest that selective agonism of the M4receptor will provide novel anti‐nociceptive agents, while therapeutics‐based upon agonism or antagonism of the muscarinic M5receptor have yet to be reported.
3 The autocrine functions of muscarinic receptors broadly fall into two areas – control of cell growth or proliferation and mediation of the release of chemical mediators from epithelial cells, ultimately causing muscle relaxation.
The former particularly are involved in embryological development, oncogenesis, keratinocyte function and immune responsiveness.
The latter regulate contractility of smooth muscle in the vasculature, airways and urinary bladder.
4 Most attention has focused on muscarinic M1or M3receptors which mediate lymphocyte immunoresponsiveness, cell migration and release of smooth muscle relaxant factors.
Muscarinic M4receptors are implicated in the regulation of keratinocyte adhesion and M2receptors in stem cell proliferation and development.
Little data are available concerning the M5receptor, partly due to the difficulties in defining the subtype pharmacologically.
5 The autocrine functions of acetylcholine, like those in the nervous system, involve activation of several muscarinic receptor subtypes.
Consequently, the role of these subtypes in autocrine, as well neuronal cholinergic systems, significantly expands their importance in physiology and pathophysiology.
Related Results
Deletion of p75NTR enhances the cholinergic innervation pattern of the visual cortex
Deletion of p75NTR enhances the cholinergic innervation pattern of the visual cortex
AbstractThe cholinergic system is involved in cortical plasticity, attention, and learning. Within the visual cortex the cholinergic system seems to play a role in visual perceptio...
PRESYNAPTIC MUSCARINIC-NICOTINIC MODULATION of GABAergic INPUTS to NEURONS in the REM SLEEP EXECUTIVE AREA of the ROSTRAL PONS
PRESYNAPTIC MUSCARINIC-NICOTINIC MODULATION of GABAergic INPUTS to NEURONS in the REM SLEEP EXECUTIVE AREA of the ROSTRAL PONS
ABSTRACT
A large body of evidence indicates that cholinergic neurons in the brainstem tegmental nuclei play a pivotal role in controlling neurons...
Functional comparison of muscarinic partial agonists at muscarinic receptor subtypes hM
1
, hM
2
, hM
3
, hM
4
Functional comparison of muscarinic partial agonists at muscarinic receptor subtypes hM
1
, hM
2
, hM
3
, hM
4
This study describes the pharmacological comparison of the muscarinic partial agonists sabcomeline, xanomeline and milameline at human cloned muscarinic receptor subtypes (hM
...
(±) Epibatidine Increases Acetylcholine Release Partly through an Action on Muscarinic Receptors
(±) Epibatidine Increases Acetylcholine Release Partly through an Action on Muscarinic Receptors
Abstract: Epibatidine has been used in a wide dose range and was found to produce both nociceptive and antinociceptive effects. The different effects were partly explained by an ac...
Do Pipecuronium and Rocuronium Affect Human Bronchial Smooth Muscle?
Do Pipecuronium and Rocuronium Affect Human Bronchial Smooth Muscle?
Background
Muscle relaxants affect nicotinic and muscarinic receptors. Interaction of muscle relaxants with muscarinic receptors of human airways has been studied incom...
Group I Metabotropic Glutamate Receptor Activation Produces a Direct Excitation of Identified Septohippocampal Cholinergic Neurons
Group I Metabotropic Glutamate Receptor Activation Produces a Direct Excitation of Identified Septohippocampal Cholinergic Neurons
Septohippocampal cholinergic neurons innervate the hippocampus and provide it with almost its entire acetylcholine. Axon collaterals of these neurons also release acetylcholine wit...
Central blockade of muscarinic cholinergic receptors disrupts affective and attentional set‐shifting
Central blockade of muscarinic cholinergic receptors disrupts affective and attentional set‐shifting
AbstractImpairments in multiple aspects of attentional and executive function follow damage to cholinergic neurons in the central nervous system. Affective and attentional set‐shif...
PromoterIV‐BDNFdeficiency disturbs cholinergic gene expression ofCHRNA5,CHRM2, andCHRM5: effects of drug and environmental treatments
PromoterIV‐BDNFdeficiency disturbs cholinergic gene expression ofCHRNA5,CHRM2, andCHRM5: effects of drug and environmental treatments
AbstractBrain‐derived neurotrophic factor (BDNF) promotes maturation of cholinergic neurons. However, how activity‐dependentBDNFexpression affects specific cholinergic gene express...

